Date | Time | Place | Session / Title | Role |
April 28 | 8:10 AM - 9:40 AM | Asan Medical Center, Seoul, Korea | Live Case Session I Asan Medical Center, Seoul, Korea: Case #2 |
2nd Operator |
April 28 | 12:45 PM - 1:05 PM | Presentation Theater 1, Level 1 | Evolut PRO Latest Innovation: A Workhorse Device to Treat All Patient Evolut PRO Latest Innovation in TAVI: A Workhorse Device to Treat All Patient |
Lecturer |
April 28 | 2:00 PM - 3:00 PM | Coronary Theater, Level 1 | TCT @ TCTAP 2019 | Panelist |
April 29 | 8:30 AM - 9:45 AM | Presentation Theater 1, Level 1 | Spotlights of Major Clinical Studies with Expert Commentary | Moderator |
April 29 | 8:53 AM - 9:00 AM | Presentation Theater 1, Level 1 | Spotlights of Major Clinical Studies with Expert Commentary Discussion: Anticoagulation for TAVR: GALILEO, and Yet It Moves. |
Discussant |
April 29 | 9:23 AM - 9:30 AM | Presentation Theater 1, Level 1 | Spotlights of Major Clinical Studies with Expert Commentary Discussion: TAVR Low Risk Trials: Can It Be Standard? |
Discussant |
April 29 | 2:00 PM - 4:00 PM | Presentation Theater 1, Level 1 | Valves | Moderator |
April 29 | 2:08 PM - 2:16 PM | Presentation Theater 1, Level 1 | Valves TAVR in 2019: Appropriate Patient and Device Selection |
Lecturer |
April 29 | 4:30 PM - 4:50 PM | Interview Lounge, Level 2 | Valve | Moderator |
April 30 | 8:35 AM - 10:20 AM | Structural Heart & Endovascular Theater, Level 1 | Live Case & Lecture Session I | Moderator |
April 30 | 10:00 AM - 10:10 AM | Structural Heart & Endovascular Theater, Level 1 | Live Case & Lecture Session I Cerebral Protection in TAVR: Which Patient Category or Anatomical Subset? |
Lecturer |
April 30 | 10:20 AM - 11:30 AM | Structural Heart & Endovascular Theater, Level 1 | Live Case Session II | Moderator |